SIMEPREVIR PLUS PEGINTERFERON/RIBAVIRIN COST-EFFECTIVENESS ANALYSIS FOR THE TREATMENT OF CHRONIC GENOTYPE 1 HEPATITIS C IN COLOMBIA

被引：1
|
作者：
Ariza, J. G. [1 ]
Taborda, A. [2 ]
Naciben, V [3 ]
Heibeck, M. [4 ]
Westerhout, K. Y. [5 ]
机构：
[1] Janssen, Bogota, Colombia
[2] Johnson & Johnson, Sao Paulo, SP, Brazil
[3] Janssen Pharmaceut, Sao Paulo, Brazil
[4] Pharmerit Int, Berlin, Germany
[5] Pharmerit Int, Rotterdam, Netherlands
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.020
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN26
引用
收藏
页码：A872 / A872
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium
    Wong, JB
    Nevens, F
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (02): : 110 - 111
  • [32] Cost-effectiveness of peginterferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C in Sweden
    Bernfort, Lars
    Sennfalt, Karin
    Reichard, Olle
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2006, 38 (6-7) : 497 - 505
  • [33] Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3
    Marciano, Sebastian
    Borzi, Silvia M.
    Dirchwolf, Melisa
    Ridruejo, Ezequiel
    Mendizabal, Manuel
    Bessone, Fernando
    Sirotinsky, Maria E.
    Giunta, Diego H.
    Trinks, Julieta
    Olivera, Pablo A.
    Galdame, Omar A.
    Silva, Marcelo O.
    Fainboim, Hugo A.
    Gadano, Adrian C.
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (04) : 703 - 709
  • [34] Sofosbuvir plus simeprevir for the treatment of genotype 1 chronic hepatitis C: a review of evidence
    Gimeno-Ballester, Vicente
    Angel Simon, Miguel
    Trigo, Cristina
    Mar, Javier
    San Miguel, Ramon
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (11) : 1289 - 1303
  • [35] Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3
    Sebastián Marciano
    Silvia M Borzi
    Melisa Dirchwolf
    Ezequiel Ridruejo
    Manuel Mendizabal
    Fernando Bessone
    María E Sirotinsky
    Diego H Giunta
    Julieta Trinks
    Pablo A Olivera
    Omar A Galdame
    Marcelo O Silva
    Hugo A Fainboim
    Adrián C Gadano
    World Journal of Hepatology, 2015, (04) : 703 - 709
  • [36] Meta-analysis: a randomized trial of peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4
    Khuroo, MS
    Khuroo, MS
    Dahab, ST
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (09) : 931 - 938
  • [37] Peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4: A meta-analysis of randomized trials
    Khuroo, MS
    Khuroo, MS
    Dahab, ST
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S100 - S100
  • [38] Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
    Isakov, Vasily
    Nikitin, Igor
    Chulanov, Vladimir
    Ogurtsov, Pavel
    Lukyanova, Ekaterina
    Long, Jianmin
    Wah, Janice
    Helmond, Frans A.
    WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (06) : 331 - 339
  • [39] Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Al-Ajmi, M
    Owaid, S
    Varghese, R
    Al-Nakib, B
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (09): : 1733 - 1737
  • [40] Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
    Vasily Isakov
    Igor Nikitin
    Vladimir Chulanov
    Pavel Ogurtsov
    Ekaterina Lukyanova
    Jianmin Long
    Janice Wahl
    Frans A Helmond
    the P08160 trial Investigators
    World Journal of Hepatology, 2016, (06) : 331 - 339
12345